475
Participants
Start Date
May 27, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
OralViome Cancer Testing System
The OralViome Cancer Testing System is intended for the screening of Oral Squamous Cell Carcinoma (OSCC) and Oropharyngeal cancer (OPC). The system consists of the OralViome Saliva Collection and Transport Kit, the Viome laboratory process for metatranscriptomics, and the Viome analytical software that detects an RNA expression signature within a saliva sample.
RECRUITING
NYMC, New York
Collaborators (1)
New York Medical College
OTHER
Viome
INDUSTRY